Bio-Preserve International Adds Noted Research Scientist and is Listed On the Berlin Stock Exchange.REDMOND, Wash.--(BW HealthWire)--July 17, 1998--Bio-Preserve International Corporation (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : BIPN) announced today that Winston Wicomb, Ph.D. has been appointed to the position of Research Scientist effective August 1, 1998. Dr. Wicomb is the Director of Transplantation Research at the California Pacific Medical Center California Pacific Medical Center (CPMC) is one of the largest private, not-for-profit, academic medical centers in Northern California. The Medical Center is a combination of three of San Francisco's oldest medical institutions: Pacific Presbyterian Hospital, Children's Hospital in San Francisco. A native of South Africa and a protege of Christiaan Barnard, Dr. Wicomb has more than 90 papers to his credit in the areas of heart transplantation Heart Transplantation Definition Heart transplantation, also called cardiac transplantation, is the replacement of a patient's diseased or injured heart with a healthy donor heart. , organ preservation, and cardioplegic fluids. He has collaborated extensively in transplantation research with Christiaan Barnard, David Cooper and, most recently, Geoffrey Collins. Dr. Wicomb earned a bachelor of science Noun 1. Bachelor of Science - a bachelor's degree in science BS, SB bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies degree in biochemistry and physiology and a Ph.D. in biochemistry at the University of Cape Town “UCT” redirects here. For other uses, see UCT (disambiguation). Medical School. "We are extremely pleased to have Dr. Wicomb join our team. His outstanding credentials and in-depth knowledge of organ transplantation The transfer of organs such as the kidneys, heart, or liver from one body to another. The transplantation of human organs has become a common medical procedure. Typical organs transplanted are the kidneys, heart, liver, pancreas, cornea, skin, bones, and lungs. make him an excellent addition to our research team," stated Arthur Karuna-Karan, Ph.D., Chief Executive Officer and Director of Bio-Preserve International. "I have been involved in organ perfusion research since the `70s. This opportunity to work with Bio-Preserve's team of scientists and engineers, as well as to utilize Bio-Preserve's LifeSustainer devices, which I consider to be the most advanced perfusion devices available today, is an exciting prospect for me," said Dr. Wicomb. Bio-Preserve International also announced that it has been listed on the Berlin Stock Exchange, trading under the symbol of "BPN BPN Business Partner Network BPN Banco Português de Negócios (Portuguese bank) BPN Banca Popolare Di Novara (Italian bank) BPN Biopartnering North America BPN Business Professional Network ". Bio-Preserve Medical Corporation, a subsidiary of Bio-Preserve International Corporation, is engaged in the research and development of organ preservation device technology based on perfusion, the circulation of fluids in an isolated organ using the organ's own vascular network. The company's products bring together the diverse components used for perfusion into clean, compact, effective, user-friendly devices. Such devices are used in biomedical research, to preserve human organs for transplants and for therapeutic treatment of isolated organs. The company also intends to provide organ preservation and perfusion research services to pharmaceutical and biotechnology companies as well as non-profit research institutions interested in using isolated organs for drug discovery and other types of biomedical research. Bio-Preserve International Corporation is quoted on the OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. as "BIPN" and trades on the Berlin Stock Exchange under the symbol of "BPN" CONTACT: For investor information: Investor Communications Co., 800/457-5580 or 800/457-5579 or Harvey Wish, 888/852-2212 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion